A detailed history of Israel Englander (Millennium Management LLC) transactions in Merck & Co., Inc. stock. As of the latest transaction made, Millennium Management LLC holds 1,796,976 shares of MRK stock, worth $179 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares
1,796,976
Previous 1,079,300 66.49%
Holding current value
$179 Million
Previous $134 Million 52.72%
% of portfolio
0.1%
Previous 0.06%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$111.15 - $128.97 $866 Million - $1 Billion
-7,788,203 Reduced 81.25%
1,796,976 $204 Million
Q2 2024

Aug 14, 2024

SELL
$123.8 - $132.96 $60 Million - $64.4 Million
-484,273 Reduced 4.81%
9,585,179 $1.19 Billion
Q1 2024

May 15, 2024

BUY
$113.24 - $131.95 $455 Million - $531 Million
4,021,500 Added 66.49%
10,069,452 $1.33 Billion
Q4 2023

Feb 14, 2024

BUY
$100.18 - $109.02 $601 Million - $654 Million
6,000,091 Added 12536.49%
6,047,952 $659 Million
Q2 2023

Aug 14, 2023

BUY
$108.61 - $118.38 $1.13 Million - $1.23 Million
10,410 Added 27.8%
47,861 $5.52 Million
Q1 2023

May 15, 2023

SELL
$102.94 - $114.86 $144 Million - $161 Million
-1,400,471 Reduced 97.4%
37,451 $3.98 Million
Q4 2022

Feb 14, 2023

BUY
$87.44 - $112.11 $8.27 Million - $10.6 Million
94,582 Added 7.04%
1,437,922 $160 Million
Q3 2022

Nov 14, 2022

SELL
$84.53 - $94.96 $138 Million - $155 Million
-1,634,914 Reduced 54.9%
1,343,340 $116 Million
Q2 2022

Aug 15, 2022

BUY
$83.49 - $94.64 $12.2 Million - $13.8 Million
146,148 Added 5.16%
2,978,254 $272 Million
Q1 2022

May 16, 2022

BUY
$73.51 - $82.4 $131 Million - $147 Million
1,783,607 Added 170.11%
2,832,106 $232 Million
Q4 2021

Feb 14, 2022

BUY
$72.28 - $90.54 $4.64 Million - $5.81 Million
64,223 Added 6.52%
1,048,499 $80.4 Million
Q3 2021

Nov 15, 2021

BUY
$71.68 - $78.83 $36.9 Million - $40.6 Million
514,993 Added 109.74%
984,276 $73.9 Million
Q2 2021

Aug 16, 2021

SELL
$70.31 - $77.77 $39.3 Million - $43.4 Million
-558,319 Reduced 54.33%
469,283 $36.5 Million
Q1 2021

May 17, 2021

BUY
$68.86 - $81.11 $20 Million - $23.6 Million
290,407 Added 39.39%
1,027,602 $79.2 Million
Q4 2020

Feb 16, 2021

BUY
$71.77 - $79.65 $5.99 Million - $6.65 Million
83,510 Added 12.78%
737,195 $60.3 Million
Q3 2020

Nov 16, 2020

BUY
$73.18 - $82.95 $27.5 Million - $31.2 Million
376,326 Added 135.68%
653,685 $54.2 Million
Q2 2020

Aug 14, 2020

SELL
$70.42 - $80.13 $98.1 Million - $112 Million
-1,392,419 Reduced 83.39%
277,359 $21.4 Million
Q1 2020

May 14, 2020

BUY
$63.36 - $87.82 $15.6 Million - $21.6 Million
245,885 Added 17.27%
1,669,778 $128 Million
Q4 2019

Feb 14, 2020

BUY
$77.58 - $87.54 $106 Million - $119 Million
1,363,355 Added 2252.06%
1,423,893 $130 Million
Q3 2019

Nov 14, 2019

BUY
$76.08 - $82.93 $3 Million - $3.27 Million
39,448 Added 187.05%
60,538 $5.1 Million
Q2 2019

Aug 15, 2019

SELL
$69.84 - $81.59 $4.91 Million - $5.74 Million
-70,304 Reduced 76.92%
21,090 $1.77 Million
Q2 2019

Aug 14, 2019

BUY
$69.84 - $81.59 $6.38 Million - $7.46 Million
91,394 New
91,394 $3.31 Million
Q1 2019

May 14, 2019

SELL
$69.58 - $79.36 $341 Million - $389 Million
-4,906,087 Closed
0 $0
Q4 2018

Feb 14, 2019

BUY
$65.24 - $75.71 $72.1 Million - $83.6 Million
1,104,867 Added 29.07%
4,906,087 $375 Million
Q3 2018

Nov 14, 2018

BUY
$57.69 - $67.84 $66.8 Million - $78.6 Million
1,157,954 Added 43.81%
3,801,220 $270 Million
Q2 2018

Aug 14, 2018

BUY
$50.83 - $59.72 $13.6 Million - $16 Million
268,391 Added 11.3%
2,643,266 $160 Million
Q1 2018

May 15, 2018

BUY
$50.96 - $59.23 $79.1 Million - $91.9 Million
1,552,401 Added 188.75%
2,374,875 $129 Million
Q4 2017

Feb 14, 2018

SELL
$51.62 - $61.64 $95.5 Million - $114 Million
-1,849,820 Reduced 69.22%
822,474 $46.3 Million
Q3 2017

Nov 14, 2017

BUY
$58.67 - $63.13 $157 Million - $169 Million
2,672,294
2,672,294 $171 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $252B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.